- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Enzalutamide – March 2017
Enzalutamide: Capsule 40 mg; Xtandi®
Last updated
14 July 2017